Fresenius Medical Care AG (FMS)

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million PR...

Form SD - Specialized disclosure report

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026 PR Newswire BAD...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with...

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney...

Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer PR Newswire BAD HOMBURG, Germany...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]